Zhejiang Zhenyuan Co., Ltd. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Zhenyuan Co., Ltd. with three other
companies in this sector in China:
Jiangsu Nhwa Pharmaceutical Company Limited
sales of 3.39 billion Chinese Renmimbi [US$494.93 million]
of which 55%
was Medical Industrial Manufacturing),
China Pioneer Pharma Holdings Ltd
(2.15 billion Chinese Renmimbi [US$314.13 million]
of which 56%
was Products sold via the provision of co-pr), and
China Resources Phoenix Healthcare Holdings Company Ltd
(1.88 billion Chinese Renmimbi [US$273.85 million]
of which 46%
was GPO business).
Zhejiang Zhenyuan Co., Ltd. reported sales of 2.58 billion Chinese Renmimbi (US$375.96 million)
December of 2017.
increase of 5.7%
versus 2016, when the company's sales were 2.44 billion Chinese Renmimbi.
Sales at Zhejiang Zhenyuan Co., Ltd. have increased during each of the previous five years
(and since 2012, sales have increased a total of 42%).
Sales of Business Service saw an increase
that was more than double the company's growth rate: sales were up
48.7% in 2017, from
6.81 million Chinese Renmimbi to 10.13 million Chinese Renmimbi.
Zhejiang Zhenyuan Co., Ltd. also saw significant increases in sales in
Medicine Retail Trade (up 15.1% to 486.15 million Chinese Renmimbi)
Medicines Manufacturing (up 29.9% to 448.15 million Chinese Renmimbi)